Skip to content

RECOGNISE: Using a Cerebral Oximeter monitoring device to identify and reduce postoperative complications in cardiac surgery

Routine usE of Cerebral Oximetry monitorinG iN cardIac SurgEry. A Randomised Controlled Single Centre Study to evaluate the use of neuromonitoring to identify and reduce postoperative complications

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12937489
Enrollment
440
Registered
2018-01-09
Start date
2018-03-01
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Medicine Surgery Anaesthesia, Perioperative Medicine and Pain Management

Interventions

Participants are recruited pre operatively either at pre-operative clinic or at the anaesthetic visit immediately prior to surgery and are asked to complete the Rey Auditory Verbal Learning Test (RAVL

Sponsors

University Hospital Of South Manchester NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Participant is willing and able to give informed consent for participation in the study 2. Male or Female, aged 18 years or above at point of consent 3. Participant is due to undergo elective or urgent cardiac surgery 4. Able (in the Investigators opinion) and willing to comply with all study requirements

Exclusion criteria

Exclusion criteria: 1. Patients undergoing emergency cardiac surgery 2. Participant undergoing transplantation surgery or Mechanical Circulatory Support Implantation surgery. 3. Participants undergoing aortic surgery with Deep Hypothermic Circulatory Arrest 4. Patients already unconscious, sedated or anaesthetised before surgery 5. Patients unable to provide informed consent 6. Significant alcohol intake preoperatively (> 50 units/week) 7. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant’s ability to participate in the study

Design outcomes

Primary

MeasureTime frame
Comparison of the primary outcome measure, delirium rate, is measured using the Rey Auditory Verbal Learning Test both immediately prior to surgery and at 6-12 weeks (+/-7 days) following extubation.

Secondary

MeasureTime frame
1. Post-operative CerebroVascular Accident CVA confirmed by CT scan as per standard care at followup within two days of surgery. 2. Post-operative renal dysfunction measured using RIFLE Scoring 3. ITU length of stay measured using hospital records at discharge 4. Post-operative Cognitive Dysfunction measured using RAVLT at 6-12week follow up

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026